Visceral adipose tissue is associated with circulating high affinity growth hormone-binding protein

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 3, 1997, Pages 760-764

  Roelen, Corné A M ^b   Koppeschaar, Hans P F ^a   De Vries, Wouter R ^b   Snel, Yvonne E M ^b   Doerga, Manorath E ^b   Zelissen, Pierre M J ^b   Thijssen, Jos H H ^b   Blankenstein, Marinus A ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; GROWTH HORMONE BINDING PROTEIN; HUMAN GROWTH HORMONE; LEVONORGESTREL; LEVOTHYROXINE; SOMATOMEDIN C; TESTOSTERONE ESTER; TESTOSTERONE UNDECANOATE;

ADIPOSE TISSUE; ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; ARTICLE; BINDING AFFINITY; BODY FAT; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VISCERA;

EID: 0031048428     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.3.3836     Document Type: Article

References (33)

1. Iranmanesh A, Lizarralde G, Veldhuis JD. 1991 Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 73:1081-1088.
2. Veldhuis JD. 1996 Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur J Endocrinol. 134:287-295.
3. Underwood LE, van Wijk JJ. 1992 Normal and aberrant growth. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology, 8th ed. Philadelphia: Saunders; 1079-1138.
4. Marcus C, Margery V, Kamel A, Brönnegård M. 1994 Effects of growth hormone on lypolysis in humans. Acta Paediatr. 406(Suppl):54-58.
5. Björntorp P. 1991 Metabolic implications of body fat distribution. Diabetes Care. 14:1132-1143.
6. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. 1990 Regional distribution of body fat, plasma lipoprotein, and cardiovascular disease. Arteriosclerosis. 10:497-511.
7. Frayn KN. 1995 The importance of muscle and fat metabolism for complications of obesity. Int J Obesity. 19(Suppl 2):16-17.
8. Reaven GM. 1993 Role of insulin resistance in human disease (syndrome-X)-an expanded definition. Annu Rev Med. 44:121-131.
9. Veldhuis JD, Iranmanesh A, Ho KKY, Waters MJ, Johnson ML, Lizarralde G. 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab. 72:51-59.
10. Jörgenson JOL, Pedersen SB, Frystyk J, et al. 1995 Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a double-blind, placebo-controlled study. Eur J Endocrinol. 133:65-70.
11. Silbergeld A, Lazar L, Erster B, Keret R, Tepper R, Laron Z. 1989 Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlations with age, height and weight. Clin Endocrinol (Oxf). 31:295-303.
12. Martha Jr PM, Rogol AD, Blizzard RM, Shaw MA, Baumann G. 1991 Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys. J Clin Endocrinol Metab. 73:175-181.
13. Rasmussen MH, Ho KKY, Kjems L, Hilsted J. 1996 Serum growth hormone-binding protein in obesity: effect of a short-term, very low calorie diet and diet-induced weight loss. J Clin Endocrinol Metab. 81:1519-1524.
14. Baumann G, Shaw MA, Amburn K. 1994 Circulating growth hormone binding proteins [Review]. J Endocrinol Invest. 17:67-81.
15. Counts DR, Gwirtsman H, Carlsson LMS, Lesem M, Butler GB. 1992 The effect of anorexia nervosa and refeeding on growth hormone binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab. 75:762-767.
16. Schaefer F, Baumann G, Haffner D, et al. 1996 Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma. J Clin Endocrinol Metab. 81:22-31.
17. Snel YEM, Brummer RJM, Doerga ME, et al. 1995 Adipose tissue by magnetic resonance imaging in growth hormone deficient adults: the effect of growth hormone replacement and a comparison with control subjects. Am J Clin Nutr. 61:1290-1294.
18. Roelen CAM, Donker GH, Thijssen JHH, Blankenstein MA. 1992 A method for measuring the binding affinity and capacity of high affinity growth hormone binding protein using FPLC to separate bound and free ligand. J Liquid Chromatogr. 15:1259-1275.
19. Davenport ML, Svoboda ME, Koerber KL, Van Wijk JJ, Clemmons DR, Underwood LE. 1988 Serum concentrations of insulin-like growth factor II are not changed by short term fasting and refeeding. J Clin Endocrinol Metab. 67:1231-1236.
20. Furlanetto RW, Underwood LE, Van Wijk JJ, d'Ercole AJ. 1977 Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest. 60:648-657.
21. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. 1985 Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 41:810-817.
22. Abate N, Burns D, Peshock RM, Garg A, Grundy SM. 1994 Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res. 35:1490-1496.
23. Fowler PA, Fuller MF, Glasbey CA, Cameron GG, Foster MA. 1992 Validation of the in vivo measurement of adipose tissue by magnetic resonance imaging of lean and obese pigs. Am J Clin Nutr. 56:7-13.
24. Bengtsson BÅ, Edén S, Lönn L, et al. 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 76:309-317.
25. Krotkiewski M, Björntorp P, Sjöström L, Smith U. 1983 Impact of obesity in metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest. 72:1150-1162.
26. Rebuffé-Scrive M, Andersson B, Olbe L, Björntorp P. 1989 Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism. 38:453-458.
27. Imaki T, Shibasaki T, Shizume K, et al. 1985 The effect of free fatty acids on growth hormone-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab. 60:290-293.
28. Casanueva FF, Villanueva L, Dieguez C, et al. 1987 Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J Clin Endocrinol Metab. 65:634-642.
29. Leung DW, Spencer SA, Cachianes G, et al. 1987 Growth hormone receptor and serum binding protein: purification, cloning, and expression. Nature. 330:537-543.
30. Davila N, Alcaniz J, Salto L, Estrada J, Barcelo B, Baumann G. 1994 Serum growth hormone-binding protein is unchanged in adult panhypopituitarism. J Clin Endocrinol Metab. 79:1347-1350.
31. Ho KKY, Jörgensen JOL, Valiontis E, Waters MJ, Rajikovic IA, Christiansen JS. 1993 Different modes of growth hormone administration do not change GH binding protein activity in man. Clin Endocrinol (Oxf). 143-148.
32. Martha PM, Reiter EO, Davila N, Shaw MA, Holcombe JH, Baumann G. 1993 Serum growth hormone (GH)-binding protein/receptor: an important determinant of GH responsiveness. J Clin Endocrinol Metab. 75:1464-1469.
33. Roelen CA, Koppeschaar HPF, de Vries WR, et al. 1996 High affinity growth hormone-binding protein, insulin-like growth factor-1 and insulin-like growth factor-binding protoin-3 in adults with growth hormone deficiency. Eur J Endocrinol. 135:82-86.